3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
54
Triple Negative Breast Neoplasms
8
Carcinoma, Intraductal, Noninfiltrating
6
Breast Neoplasms, Male
4
Melanoma
3
Inflammatory Breast Neoplasms
3
Breast Carcinoma In Situ
3
Brain Neoplasms
3
Sarcoma
2
Prostatic Neoplasms
2
Lung Neoplasms
2
Carcinoma, Merkel Cell
2
Carcinoma, Ductal, Breast
2
Bone Neoplasms
2
To Evaluate the Safety of Taurine in Preventing Acute Radiation Skin Injury Induced by Adjuvant Radiotherapy in Breast Cancer Patients
1
Squamous Cell Carcinoma of Head and Neck
1
Pain
1
Osteosarcoma
1
Neoplasms
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Meningeal Carcinomatosis
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Glioblastoma
1
Fatigue
1
Estrogen Receptor Positive
1
Deception
1
Cardiotoxicity
1
Carcinoma, Squamous Cell
1
Interventions
Letrozole
5
Radiotherapy
4
Carboplatin
4
atamestane
3
Trastuzumab
3
Toremifene
3
Docetaxel
3
Cyclophosphamide
3
Chemotherapy, Adjuvant
3
Tamoxifen
2
Paclitaxel
2
Gene Expression Profiling
2
Fulvestrant
2
Estrogen Receptor Modulators
2
Capecitabine
2
Aromatase Inhibitors
2
Amplified Fragment Length Polymorphism Analysis
2
palbociclib
1
Zolpidem
1
Vorinostat
1
Vinorelbine
1
Venlafaxine Hydrochloride
1
Thiotepa
1
Taxes
1
Sugars
1
Reverse Transcriptase Polymerase Chain Reaction
1
Radiotherapy, Conformal
1
Radiosurgery
1
Radiomics
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Lobular
×
Radiation
×
Breast
×
Clear all
NCT01819233
2025-06-06
CAREFOR
Thomas Jefferson University
Phase NA
Completed
38 enrolled
10 charts